TOP TIERMARKET NEWSWIRE

News & sentiment

ARVINAS INC (ARVN) — News & AI sentiment

ARVINAS INC (ARVN) news roundup. 1 story in the past week, 5 over 30 days. Average 30-day sentiment is 61.6/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $46K — net selling of $46K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

1

avg sentiment 56/100

30d stories

5

avg sentiment 61.6/100

Insider net (90d)

$46K

0 buys · 1 sells

Congress (90d)

0

0 buys · 0 sells

ARVN news in the last 24 hours, 7 days, 30 days and 90 days

How much ARVN coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	ARVN stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	1	56/100	ARVN headlines →
Last 30 days	5	61.6/100	ARVN headlines →
Last 90 days	24	56.1/100	ARVN headlines →

Latest stories on ARVN

Arvinas, Inc. (ARVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking Alpha56 · neutralgeneral

1d ago

Arvinas (ARVN) Just Made Protein Degrader History With FDA Nod

Yahoo Finance78 · bullishproduct/pr

Sep 9

Arvinas to Participate in Upcoming Investor Conferences

GlobeNewswire56 · neutralgeneral

Sep 3

Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire50 · neutralgeneral

Sep 1

Arvinas: Veppanu Approval Underlines Degrader Platform Promise - I'm Bullish

Seeking Alpha68 · bullishanalyst

Aug 28

Arvinas (ARVN) Q2 2026 Earnings Call Transcript

The Motley Fool73 · bullishearnings

Aug 11

Arvinas Price Target Lowered To 10 From 11 At Morgan Stanley

The Fly34 · bearishanalyst

Aug 10

Arvinas price target lowered to $14 from $19 at Evercore ISI

The Fly34 · bearishanalyst

Aug 10

Arvinas Price Target Lowered To 21 From 24 At Citi

The Fly34 · bearishanalyst

Aug 10

Arvinas Launches New Cancer Combo Trial, Adding Fresh Optionality to ARVN

TipRanks63 · neutralproduct/pr

Aug 6

BTIG reiterates Arvinas stock Buy rating on pipeline execution

Investing.com Analyst Ratings63 · neutralanalyst

Aug 4

Arvinas expects cash runway into the second half of 2028 as ARV-102 PSP trials shift to 2027

Seeking Alpha56 · neutralgeneral

Aug 4

Arvinas, Inc. (ARVN) Q2 2026 Earnings Call Transcript

Seeking Alpha50 · neutralearnings

Aug 4

ARVN Sees Landmark PROTAC Approval and Revenue Surge as Pipeline Advances Toward Major Clinical Milestones August 4, 2026

MarketChameleon78 · bullishproduct/pr

Aug 4

Why is Arvinas stock surging today?

Investing.com Markets50 · neutralgeneral

Aug 4

Arvinas Secures First PROTAC Approval and Delivers Landmark Revenue in Q2 2026—Multiple Clinical Milestones Ahead August 4, 2026

MarketChameleon78 · bullishproduct/pr

Aug 4

Arvinas GAAP EPS of $2.58 beats by $2.87, revenue of $249.7M beats by $189.01M

Seeking Alpha68 · bullishearnings

Aug 4

ARVINAS, INC. (ARVN) files 8-K

SEC 8-K50 · neutralgeneral

Aug 4

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

StockTitan59 · neutralproduct/pr

Aug 4

Arvinas Q2 2026 Earnings Preview

Seeking Alpha48 · neutralearnings

Aug 3

Arvinas to Report Second Quarter 2026 Financial Results on August 4, 2026

Business Insider50 · neutralgeneral

Jul 28

ARVINAS, INC. (ARVN) files 8-K

SEC 8-K50 · neutralgeneral

Jun 25

Arvinas Announces Chief Medical Officer Leadership Transition

TipRanks50 · neutralgeneral

Jun 22

ARVINAS, INC. (ARVN) files 8-K

SEC 8-K50 · neutralgeneral

Jun 22

Rigel to roll out Veppanu in August; Arvinas, Pfizer snag $70M upfront on cleared deal

Seeking Alpha67 · bullishm&a

Jun 17

Open ARVN in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →